AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011
Apr 15, 2011
30583_dirs_2011-04-15_a583d854-21fa-422b-99ac-4ccf0efd8d7c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-04-13
Reporting Person: Wood Mark (VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-04-13 | Common Stock | M | 83 | $17.86 | Acquired | 14326 | Direct |
| 2011-04-13 | Common Stock | M | 625 | $17.33 | Acquired | 14951 | Direct |
| 2011-04-13 | Common Stock | S | 708 | $26.00 | Disposed | 14243 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-04-13 | Stock Option (right to buy) | $17.86 | M | 83 | Disposed | 2018-12-16 | Common Stock (83) | Direct |
| 2011-04-13 | Stock Option (right to buy) | $17.33 | M | 625 | Disposed | 2017-06-06 | Common Stock (625) | Direct |
Footnotes
F1: Transaction made pursuant to a Rule 105-1 Trading plan executed on August 20, 2010.
F2: Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter.
F3: Original option grant vests 6/48th on December 7, 2007 and 1/48th each on the 7th of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19